newsfilter
← Latest News
GlobeNewswire·

KemPharm Announces Appointment of Christopher Posner as New Independent Director

24-year global pharmaceutical executive and current president and CEO of Cara Therapeutics joins KemPharm's Board of Directors CELEBRATION, Fla., Nov. 29, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH)